Services Sector Weeks 20% Losers: China Distance Education (NYSE:DL), CHC (NYSE:HELI), Bridgepoint Education (NYSE:BPI), China Lodging Group (NASDAQ:HTHT)

China Distance Education Holdings Limited (NYSE:DL) (“CDEL”, or the “Company”), a leading provider of online education in China focusing on professional education, today announced that the follow-on public offering of an aggregate of 4,000,000 American Depositary Shares (“ADSs”) by the Company and several selling shareholders was priced at US$21.00 per ADS. China Distance Education Hldgs Ltd (ADR) (NYSE:DL) stock performance was -1.84% in last session … Continue reading Services Sector Weeks 20% Losers: China Distance Education (NYSE:DL), CHC (NYSE:HELI), Bridgepoint Education (NYSE:BPI), China Lodging Group (NASDAQ:HTHT)

FB Nasdaq FB Facebook

Losers at NYSE: Aeropostale Inc. (NYSE:ARO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Empresas ICA (NYSE:ICA), XO Group (NYSE:XOXO)

Aeropostale Inc. (NYSE:ARO) reported a fourth quarter adjusted loss of $0.35 per share after the close Thursday, compared to the consensus estimate of a loss of $0.31 per share. Aeropostale Inc. (NYSE:ARO) stock performance was -20.14% in last session and finished the day at $5.83. Traded volume was 37.47 million shares in the last session and the average volume of the stock remained 3.19 million … Continue reading Losers at NYSE: Aeropostale Inc. (NYSE:ARO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Empresas ICA (NYSE:ICA), XO Group (NYSE:XOXO)

FB Nasdaq FB Facebook

Gainers At NYSE: Companhia Siderurgica Nacional (NYSE:SID), GameStop Corp. (NYSE:GME), Generac Holdings (NYSE:GNRC), Spirit Realty Capital (New) (NYSE:SRC)

Companhia Siderurgica Nacional (NYSE:SID) is a Brazil-based company primarily engaged in the steel industry. The Company divides its business into five segments: Steel sector, which is involved in the production, distribution and marketing of flat steel, galvanized steel and metal packaging. Companhia Siderurgica Nacional (ADR) (NYSE:SID) stock performance was 12.64% in last session and finished the day at $4.10. Traded volume was 14.39 million shares … Continue reading Gainers At NYSE: Companhia Siderurgica Nacional (NYSE:SID), GameStop Corp. (NYSE:GME), Generac Holdings (NYSE:GNRC), Spirit Realty Capital (New) (NYSE:SRC)

Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Tengion, Inc. (OTCMKTS:TNGN) on Mar. 3 issued notices to the holders (the “2012 Investors”) of senior secured notes issued on October 2, 2012 and to the holders (the “2013 Investors” and together with the 2012 Investors, the “Investors” and each, an “Investor”) of senior secured notes issued on June 28, 2013 stating that the Company plans to issue shares of common stock, $0.001 par value … Continue reading Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Biotech active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Ariad Pharmaceuticals (NASDAQ:ARIA)

Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. Pfizer Inc. (NYSE:PFE) stock performance was 0.35% in last session and finished the day at $31.23. Traded volume was 27.11 million shares in the last session and the average volume of the stock remained 27.87 million shares. The beta of … Continue reading Biotech active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Ariad Pharmaceuticals (NASDAQ:ARIA)

Biotech Stocks New Highs: Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN), Celladon Corp (NASDAQ:CLDN), Kindred Biosciences (NASDAQ:KIN)

Fate Therapeutics, Inc. (NASDAQ:FATE) announced that it has enrolled the first patient in its phase II study (PUMA − P rohema in UM bilical cord blood transplant in A dults) on Prohema. Fate Therapeutics Inc. (NASDAQ:FATE) stock performance was 27.14% in last session and finished the day at $11.15. Traded volume was 295,227.00 shares in the last session and the average volume of the stock … Continue reading Biotech Stocks New Highs: Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN), Celladon Corp (NASDAQ:CLDN), Kindred Biosciences (NASDAQ:KIN)